Our mission is to provide education and resources to those that desire optimum health through a holistic alternative approach which includes: proper nutrition and water, positive attitude, movement/exercise, avoidance of toxic chemicals, stress reduction and coping skills, spirituality, self-empowerment, research, new developments and alternative treatments.
Wednesday, October 26, 2011
Negative Field Magnetic Therapy
Forget everything you've ever read or heard about magnet therapy in the mainstream that didn't mention the importance of polarity! Polarity is the single most critical factor in the use and application of magnets to the body for healing! (biomagnetics) It is estimated that about 80% of all magnetic therapy products sold today are not proper polarity.
WHAT MAGNETIC THERAPY DOES
The biological response to a static positive magnetic field is acid-hypoxia. The biological response to the static negative magnetic fieldis alkaline-hyperoxia. Positive magnetic field therapy is limited to brief exposure to stimulate neuronal and catabolic glandular functions. Positive magnetic field therapy should be under medical supervision due to the danger of prolonged application, producing acid-hypoxia.
Negative magnetic field therapy has a wide application in such things as cell differentiation, healing, production of adenosine triphosphateby oxidative phosphorylation and processing of toxins by oxidoreductase enzymes and resolution of calcium and amino acid insoluble deposits. Negative magnetic field therapy is not harmful and can effectively be used both under medical supervision and self-help application. Some of the values of magnetic therapy are:
•Enhanced sleep with its health-promoting value by production of melatonin.
•Enhanced healing by production of growth hormone.
•Energy production by virtue of oxidoreductase enzyme production of adenosine triphosphate and catalytic remnant magnetism.
•Detoxification by activation of oxidoreductase enzymes processing free radicals, acids, peroxides, alcohols and aldehydes.
•Pain resolution by replacing acid-hypoxia with alkaline-hyperoxia.
•Reversal of acid-hypoxia degenerative diseases by replacement of acid-hypoxia with alkaline-hyperoxia.
•Antibiotic effect for all types of human invading micro-organisms.
•Cancer remission by virtue of blocking the acid-dependent enzyme function producing ATP by fermentation.
•Resolution of calcium and amino acid insoluble deposits by maintaining alkalinization.
•Neuronal calming providing control over emotional, mental and seizure disorders. “Magnetic therapy has been observed to have the highest predictable results of any therapy I have observed in 40 years of medical practice. ”William H. Philpott, M.D.
ABOUT WILLIAM H. PHILPOTT, M.D. William H. Philpott, M.D. has specialty training and practice in psychiatry, neurology, electroencephalography, nutrition, environmental medicine and toxicology.
JES Organics became a source for the superb American Made Polar Power magnet therapy products because these products were recommended to our founder by her doctor for Lyme Disease and the associated health issues and for her husband's osteoporosis.
Monday, May 24, 2010
Ostera™: Revolutionary Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
San Clemente, CA (March 9, 2009) — Metagenics, Inc. said today that it has launched a new nutraceutical called Ostera. This unique nutritional supplement supports the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.*
Ostera is formulated to target bone remodeling, the normal lifelong process whereby old or damaged bone tissue is replaced by new bone tissue.
Conventional approaches to postmenopausal bone health may have adverse affects or not be well-tolerated. By contrast, Ostera is a gentle, all-natural formula without reported serious adverse effects.
Ostera is intended to complement natural bone mineralization support products, such as calcium and other minerals.* Its active ingredients are:
· Extracts from berberine and rho iso-alpha acids from hops — key botanical compounds shown to beneficially influence key markers of bone remodeling. In postmenopausal women, a decline in estrogen levels can contribute to changes in bone remodeling, where the rate of bone breakdown outpaces the rate of new bone formation.*
· Vitamin K – necessary for the metabolism of bone proteins crucial to bone integrity.*
· Vitamin D – associated with healthy bone formation and bone mineralization.*
Ostera was developed using Metagenics’ proprietary nutraceutical development model called the ExpresSyn® process. This exclusive model combines cellular research, safety evaluations, human ex vivo research, and clinical research. Through the ExpresSyn Process, Metagenics researchers have discovered a new generation of natural ingredients, such as acacia and hops, which function at the cellular level as selective kinase response modulators (SKRMs).*
Clinical research included a randomized, single-blinded, placebo-controlled study in which 77 postmenopausal women with low estrogen were placed on a lifestyle change program that included a Mediterranean-style, low-glycemic-load diet and 150 minutes of moderate exercise per week. The participants in the “Ostera arm” received the supplement twice daily for twelve weeks following a two-week run-in phase. The participants in the “control arm” received a placebo.
According to Joseph J. Lamb, MD, Metagenics Director of Intramural Clinical Research, “The Ostera arm reported no serious adverse affects and showed greater improvement in key biomarkers of bone remodeling.”* These biomarkers included:
· Osteocalcin (OC), an indicator of the rate of bone remodeling. A lower level of serum OC, moving towards reference range, is associated with a slower rate of bone breakdown in postmenopausal women. The Ostera arm displayed a statistically significant reduction in serum OC, while the control arm displayed an increase.*
· Insulin-like growth factor-1 (IGF-1), a recognized marker of bone formation and important in the maintenance of a healthy skeleton. IGF-1 declines after menopause. Both arms displayed a statistically significant increase in serum IGF-1; however the Ostera arm showed a greater average increase.*
· Vitamin D, which influences bone formation and is critical for calcium absorption to facilitate mineralization. The Ostera arm displayed a statistically significant increase in vitamin D status. The control arm displayed a decrease.*
· OC/Urinary N-telopeptide of type 1 procollagen (NTx), a marker of bone resorption. Ostera arm participants with high baseline NTx levels displayed a statistically significant reduction in serum OC. Control arm participants with high baseline NTx levels displayed an increase in serum OC.*
“Early on, we identified a need for a clinically tested, all-natural formula to support healthy bone remodeling,” said Lamb. “We believe Ostera fills that gap, thereby providing a further degree of support to postmenopausal women for whom bone mineralization support products, such as calcium and other minerals, may not be enough.” As with all Metagenics nutritional formulas, Ostera is only available through licensed health care practitioners.
Individuals interested obtaining Ostera should contact their health care professionals. Meta-eHealth
About Metagenics, Inc.
Metagenics, headquartered in San Clemente, CA, is a global life sciences company focused on reversing chronic illness and improving health. Founded in 1983, the company serves tens of thousands of health care professionals and more than a million patients throughout the world and holds more than 40 propriety formula patents for use in nutraceucials, medical foods, and pharmaceuticals. Today, Metagenics continues its leadership role by successfully merging the disciplines of nutritional genomics, functional medicine, and therapeutic lifestyle change programs to find solutions to society’s most pressing health concerns.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. ####
Wednesday, February 11, 2009
Microcrystalline Hydroxyapatite Concentrate (MCHC)
In addition, MCHC has been shown to contain biologically active growth factors. Such growth factors are known to directly stimulate bone cell activity thereby enhancing bone formation.
With the rapid aging of the population, experts agree that prevention is the most effective method of dealing with osteoporosis. Along with regular exercise as well as a healthy diet and lifestyle, MCHC provides comprehensive bone nourishment which aims at preventing the onset of osteoporosis and many other health problems.
Uses
- Excellent source of bioavailable calcium.
- Provides a full complement of minerals that are important for healthy bone formation and metabolism such as phosphorus, fluoride, magnesium, silicon, iron, zinc, copper, and manganese.
- Contains intact organic factors that provide secondary support for healthy bone formation.
In several studies, MCHC has been shown to be highly successful in minimizing bone loss as well as positively affecting bone healing. This includes reducing the incidence of fractures as well as facilitating the healing of fractures.
MCHC is available in tablet form. Be sure to drink 6 to 8 cups of water throughout the day to avoid constipation. Studies have shown that 500 mg of MCHC yield approximately 200 mg of elemental calcium and thus, MCHC should be taken according to the following guidelines:
- Adults ages 19 to 50 need 2,500 mg per day of MCHC (1,000 mg of calcium). After age 50, adults need 3,000 mg per day of MCHC (1,200 mg of calcium).
- Adolescents ages 9 to 18 need 3,250 mg per day of MCHC (1,300 mg of calcium).
- Children ages 6 to 8 need 2,000 mg per day of MCHC (800 mg of calcium); children ages 1 to 5 need 1,250 mg per day of MCHC (500 mg of calcium).
Precautions
Talk with your healthcare provider about your calcium needs if you have any thyroid or kidney problems, or if you have hormone or vitamin deficiencies.
Be especially careful when choosing an MCHC product. It is important to realize that supplements that claim to contain MCHC may vary widely in purity, form, and effectiveness.
The sources of bone extract as well as the processing procedures are of utmost importance in determining the quality of MCHC. Some sources of MCHC may contain high levels of lead and other contaminants, or be tainted with cartilage and tendons. Certain processing procedures, such as high-heat and excessive grinding, can result in a product that is nothing more than bone meal. These products lack the full complement of minerals, organicfactors, and the microcrystalline structures that are characteristic of true MCHC.
Possible Interactions
Some foods, drinks, and medications can cause you to excrete MCHC. These include some soft drinks, aluminum-containing antacids, salt, sugar, saturated fat, caffeine, alcohol, and very high protein and fiber intake.
In addition, excessive amounts of some foods and drinks and regular use of some medications make it hard for your body to get the MCHC it needs. These include alcohol, aspirin, barbiturates, fiber, neomycin, strong sedatives, oxalic acid (found in chocolate, rhubarb, spinach, chard, sweet potatoes, and dried beans), phytic acid (found in grains), and uronic acid (a type of fiber found in fruits and vegetables).
Supporting Research
Epstein O, Kato Y, Dick R, et al. Vitamin D, hydroxyapatite and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982;36(3):426-30.
Fleming KH, Heimbach JT. Consumption of calcium in the U.S.: food sources and intake levels. J Nutr 1994;124(8 suppl):1426S-30S.
Pines A, Raafat H, Lynn AH, et al. Clinical trial of MCHC in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin 1984:8(10):734-42.
Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Eng J Med 1986;314(26):1676-86.
Notelovitz M. Osteoporosis: screening, prevention and management. Fertil Steril 1993;59(4):707-25.
Ruegsegger P, Keller A, Dambacher MA. Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteo Int 1995;5(1):30-34.
Stepan JJ, Pospichal J, Presl J, et al. Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women. Bone 1989;10(3):179-85.
Windsor ACM, Misra DP, Loudon JM, et al. The effect of whole-bone extract on 47Ca absorption in the elderly. Age & Ageing 1973;2(4):230-34.
Advanced Nutrition Publications ©2002
Magnesium supplementation and osteoporosis
According to researchers, "With this degree of supporting evidence, it is curious that magnesium supplementation has not been examined more frequently in studies of osteoporosis."
Osteoporosis is a reduction in bone mass that leads to an increased risk of bone fractures. In response to the lack of research on magnesium and osteoporosis, researchers reviewed a 2-year study performed on 31 osteoporotic postmenopausal women given magnesium. For the first 6 months, participants were treated with 250 to 750 mg per day of magnesium (depending upon individual tolerance). From month 6 to 24, treatment consisted of 250 mg per day of magnesium. An age-matched group consisting of 23 postmenopausal women with osteoporosis served as controls (untreated) for comparison. Bone mineral density tests were performed on all participants at the beginning of the study, after 1 year of treatment, and at the end of the 2-year study.
Researchers stated that, "At the end of the 2-year study, magnesium therapy [appeared] to have prevented fractures and resulted in a significant increase in bone density."
Researchers also claimed, "The finding that magnesium supplementation actually caused increased bone density rather than a stabilization of existing bone density is noteworthy. This has not been a finding of either calcium or estrogen intervention trials."
J. Sojka and colleagues concluded in Nutrition Reviews that "...magnesium intake should be measured when conducting studies investigating the importance of nutrients on the prevention or treatment of osteoporosis."
Nutr Rev 1995;53(3):71-80.
Advanced Nutrition Publications ©2002
Buy Magnesium Supplement - Quality - Highly Absorbable
Saturday, September 15, 2007
OSTEOPOROSIS
September 10th, 2007
A lot of HSI readers have been asking about mainstream osteoporosis drugs like Boniva, Fosamax, and Reclast – the newest once-a-year IV treatment. They’ve been concerned about potential side effects, and want to know if there are any safe, natural, effective alternatives out there. There are, and we’ll get to those in a minute.
But first let’s address the potential side effects of standard prescription drugs for osteoporosis. There are different brands of osteoporosis drugs – though most are in the same class of drugs called bisphosponates – and each comes with its own (pretty long) list of negative side effects. As you’d expect, though, there’s a lot of side effect crossover within the bisphosphonate family.
Typically, bisphosphonates (which include drugs such as Fosamax, Boniva and Actonel) require standing for at least 30 minutes (sometimes as long as 60 minutes) after you take them – no drinking or eating during that time, either. That’s because they’re hard for your body to absorb. Along with that annoyance – and, believe me, you HAVE to do it if you take these drugs – come the side effects (to keep this post from getting too long, I’ve only included about a dozen).
These may include:
· flu-like symptoms· diarrhea or constipation· bloody vomit· bone, joint, and muscle pain· back, arm and leg pain· headaches· eye pain· painful urination· blisters or peeling skin· swollen or painful gums· jawbone problems, including numbness and heaviness· death of the jawbone (yes, you read that right) Luckily, you have a lot of safe, natural choices when it comes to treating and preventing osteoporosis. Here are a couple of the most studied. For a more complete listing of alternatives, you can search through the HSI Archives.
Monitor your minerals. Most people load up on the calcium when they’re worried about osteoporosis, but that’s NOT the right thing to do. What’s even more important than getting enough calcium is absorbing and retaining enough calcium. In fact, just taking calcium mega-doses can negatively impact your overall health. Instead of increasing your calcium intake, make sure you’re getting enough of these supporting players: magnesium, manganese, potassium, Vitamin D, Vitamin C, Vitamin B-12, phosphorous, boron and plenty of essential fatty acids (like omega-3s).
Try going gluten-free. More than 1.5 million people in the U.S. may have celiac disease (CD), a condition in which gluten (a component of grains) reduces the small intestine’s ability to absorb essential nutrients, including calcium. Unfortunately, many people don’t even know they have it. But a 2005 study found a strong link between CD and osteoporosis. When newly diagnosed CD patients switched to gluten-free diets, their bone density improved.
To learn about one proven natural bone-building formula, check out this free report from the HSI research team.
Hope says: there are natural and more effective ways to treat osteoporosis. Please check them out before going the drug route!